Galicia Biodays Partnering

12–13 jun 2024 | Vigo, España

Proyecto de cooperaciónActualizado el 20 de mayo de 2024

New vaccine platform

Fernando Casal

Knowledge Transfer & International Projects en CiQUS - Center for Research in Biological Chemistry and Molecular Materials

Santiago de Compostela, España

Acerca de

Subunit vaccines with intrinsic adjuvancy, overcoming drawbacks of inactivated or attenuated vaccines.

Our platform allows the production of Microspheres (400 - 4000 nm) loaded with the proteins of interest, made in any expression system (mammalian, baculovirus, bacteria).

Concept demonstrated in animal healthcare. Recombinant vaccine incorporating Bluetongue (BTV) or African Horse Sickness viruses epitopes has generated significant levels of neutralizing antibodies, protecting mice towards a lethal challenge.

SARS-COV-2 vaccine project funded by European Vaccine Initiative (EVI) and Spanish funds.

Oportunidades similares

  • Proyecto de cooperación

    Precision Antibacterial Agents:

    Fernando Casal

    Knowledge Transfer & International Projects en CiQUS - Center for Research in Biological Chemistry and Molecular Materials

    Santiago de Compostela, España

  • Servicio

    CDMO

    • Manufacturing

    Camino Romera Mirón

    Business Developer en CZ Vaccines

    Porriño, Galicia, España

  • Proyecto de cooperación

    Enzyme Immobilization & Stabilization. Biomed Applications

    • Planning
    • Research
    • Technical

    Fernando Casal

    Knowledge Transfer & International Projects en CiQUS - Center for Research in Biological Chemistry and Molecular Materials

    Santiago de Compostela, España